chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt like might pass out; Proceeded to become limp, pale and sweaty; Proceeded to become limp, pale and sweaty; Hands rhythmically twitched back and forth; A spontaneous report was received from a nurse concerning a 32-year-old, male, patient who received Moderna's COVID-19 vaccine (mRNA-1273) and felt like he might pass out, became limp, pale, and sweaty, and hands rhythmically twitched back and forth.   The patient's medical history included allergy to penicillin. No relevant concomitant product use was reported.   On 28 Dec 2020, approximately three minutes prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 28 Dec 2020, the patient began to feel like he was going to pass out minutes after receiving the vaccine.  He became more limp, pale, and sweaty and his hands rhythmically twitched back and forth.  His eyes closed and he leaned back in his chair, but he remained upright. The nurse elevated his feet, fanned his face and upper body, and applied wet paper towels to the back of his neck.  After approximately two minutes, the patient's level of consciousness returned to baseline and he felt better after five minutes. He remained seated and sipped water for 30 minutes.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, felt like he might pass out, became limp, pale, and sweaty, and hands rhythmically twitched back and forth, was considered resolved on 28 Dec 2020.; Reporter's Comments: This case concerns a 32-year-old, male, patient, who experienced a serious unexpected event of presyncope and non-serious unexpected event of pallor, hyperhidrosis This case concerns a 32-year-old, male, patient, who experienced a serious unexpected event of presyncope and non-serious unexpected event of pallor, hyperhidrosis and muscle twitching. The event occurred 15 min after first dose of mRNA-1273, lot # 011J20A. Treatment included no medications, but feet elevation and wet towel on the back of his neck. Based on the current available information and temporal association between the use of the product and onset of the events a causal relationship cannot be excluded.
Patient became dizzy  after receiving vaccine and at the five minute mark, patient became unresponsive.  His eyes rolled back in his head but stayed open. His jaw became very clinched.  He was sweating profusely and not aware of anything goin g on around him.  This lasted somewhere between 3-5 minutes.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    Concurrent medical conditions included Crohn's disease (Moderate to severe).   On 01-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free, Solution for injection in pre-filled pen. On 03-Jan-2022, the patient experienced COVID-19 (COVID-19). In January 2022, COVID-19 (COVID-19) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jan-2022, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications were reported. No treatment medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Company comment: This spontaneous case concerns a 36 year old female patient, with no relevant medical history, who experienced the unexpected non serious AESI of COVID-19, about 3 months and 2 days after receiving the first dose with mRNA-1273 vaccine in the COVID-19 vaccination series. She received the second dose with the same vaccine according to the recommended schedule. She tested positive for SARS COV 2 test. No further information on risk factors, co morbidities, investigations and treatment was available in the report. The event recovered. Co suspect adalimumab could be a risk factor for the event. COVID-19 pandemia could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 36 year old female patient, with no relevant medical history, who experienced the unexpected non serious AESI of COVID-19, about 3 months and 2 days after receiving the first dose with mRNA-1273 vaccine in the COVID-19 vaccination series. She received the second dose with the same vaccine according to the recommended schedule. She tested positive for SARS COV 2 test. No further information on risk factors, co morbidities, investigations and treatment was available in the report. The event recovered. Co suspect adalimumab could be a risk factor for the event. COVID-19 pandemia could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
little bump on arm; redness on arm; fever; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (little bump on arm), VACCINATION SITE ERYTHEMA (redness on arm), the first episode of PYREXIA (fever), MYALGIA (body aches) and the second episode of PYREXIA (fever) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced the first episode of PYREXIA (fever), MYALGIA (body aches) and the second episode of PYREXIA (fever). On 06-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on arm). On 07-Mar-2021, the patient experienced VACCINATION SITE MASS (little bump on arm). On 06-Feb-2021, MYALGIA (body aches) and the last episode of PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE MASS (little bump on arm) and VACCINATION SITE ERYTHEMA (redness on arm) outcome was unknown.            No treatment medication provided. No concomitant medication was reported by the reporter.   This case was linked to MOD-2021-037275 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: TCR : AE outcome/ patient don't want to further follow-ups.
Dizziness, chills, bedridden for 31 hours, no appetite, hardness and soreness not at injection site but further down arm near elbow.
This case was reported by a pharmacist and described the occurrence of shoulder pain in a female subject of unspecified age who was vaccinated with Hepatitis B vaccine for prophylaxis. In September 2007 the subject received 1st dose of Hepatitis B vaccine (unknown). In September 2007, less than one day after vaccination with Hepatitis B vaccine, the subject experienced shoulder pain. The patient required medical attention in the emergency room. It was unknown whether the subject was hospitalized or stayed overnight in the emergency room. At the time of reporting the event was unresolved. It is unknown if the subject had experienced any adverse events following previous vaccinations.
"ee noticed a weird sensation when the vaccine was given. ee felt like the vaccine was given lower than it normally is.  ee felt pain down the right arm later that day. pain eased up over a few days - the pain would come and go in the days following.  This went on for a couple months before it spread more into the shoulder, this gradually increased to be felt more consistently throughout the arm. Around the first of January it started to ache into the backside of the right neck and a achy feeling like getting ready to have a headache. Down toward the elbo it feels achy. Over the last month, it is difficult to sleep, the pain starts to wake him up. Has started to affect the ROM, like pulling pants up, reach across to get the seatbelt. Use of tylenol. Tylenol usually helps the pain. "
A little past 24 hours after the 2nd dose I started to experience (what I now know) skipped beats/palpations in my heart. My heart has been great since ablation in August 2020. It has taken several calls and trip to heart doctor that I was not having SVT episodes but many skipped beats. My heart rate was okay. I had to avoid caffeine for theses two plus weeks for my heart to settle down. I was very concerned because I had no issue with my heart ( have LINQ implant)  since August. I also had -migraine headache, exhaustion, 100 fever for a day
Felt nausea, low grade fever, headache and diaphoretic continues to have these symptoms 3 days later.
Facial swelling, shortness of breath, nasal stuffiness, tachycardia >150, IV solumedrol, Benadryl and Pepcid  Relief in symptoms upon discharge at 2330
Pfizer Biontech Adult formulation, 0.2ml,  given to 10 y/o child.  No adverse s/s reported from parent.
Suspected Vaccination Failure; terrible case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient was the reporter's coworker. The age at vaccination was not reported. After receiving Shingles vaccine, the patient came down with a terrible case of shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Tdap erroneously administered ID insteat of IM. Local reaction on forearm noted on 17 Oct 2014.
After I have received the COVID vaccine, I have experienced an increase in gastrointestinal issues. My excretions have been mucusy and runny. I also have experienced an increase in acid reflux, there is a dull pain in my abdomen, and every time I eat, my stomach hurts every time I eat. I have also been known to get more nauseous more often, and my excretions sometimes are followed by a bit of blood in them. I experience pain when I poop, as well. I am currently undergoing labs and ultrasounds to figure what is going on.
Patient developed pain in left leg and wouldn't move it on 10/28/13 (7 days after receiving flu vaccine in the left thigh). MRI showed diffuse myositis of the left quadriceps. Pt did have adenovirus diagnosed on 10/15/13 after febrile seizure 10/14/13 with full septic w/u.
Onset of symptoms was 30 hours post-injection including pain and swelling at the injection site and within a few hours the pain expanded throughout the deltoid muscle.  In the days that followed, the pain extended from left shoulder through the deltoid and outside of forearm into the left most fingers of left hand.  Two weeks following loss of sensation occurred in left most finger of left hand and half of the adjacent finger and entire left arm weakness was remarkable.  Two months after injection, bruising and swelling was remarkable at the injection site.  At three months, bruising diminished.  At four months, swelling diminished.  Ongoing symptoms include loss of sensation and strength in left most fingers of left hand. and strength is entire left arm has shown no improvement as of the date of this report.
03/26 Prolonged deep muscle pain. Left arm did not respond to over the counter pain meds. Tingling along underside of arm and numbness in fingers for 2-3 days after immunization. Difficulty in lifting arm beginning 03/26.
Pain + redness localized to the injection site (normal level after an injection) started immediately The day after the injection, the area under it started to get a little hard (about 2/3 of an inch across, and 1/2 an inch deep. On day 7, the red area began receding, and is only slightly warmer than the surrounding skin. The lump under the injection site remains, but is less tender.
On evening after receiving vaccine pt reported developing severe pain in arm preventing sleep. As of the following morning, she also reported chills, nausea, and widespread muscle pain. She denied any redness or swelling around injection site.
Immediate side effects:  Heavy brain fog, odd soreness all over my body in my muscles/vascular system (sore neck, wrists, lower back), I felt a pressure in my heart like it had swollen or something, ringing in ears, muscle twitching like I had just gotten off of a long run. Ejaculation was yellow for about a week with a different texture than normal texture (which is back to normal seemingly now).   Longer side effects: Overall it took about 2 weeks before I felt back to normal. Lingering issues are some slight inter-muscular pains that didn't exist before.
The patient experienced redness and swelling at the injection site. The swelling was the size of a half dollar. The patient was observed in the clinic on 11/08/2001, and the swollen area was 3cm in diameter.
shingles; rash on chest and arms; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) and RASH (rash on chest and arms) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04013213a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles) and RASH (rash on chest and arms). At the time of the report, HERPES ZOSTER (shingles) had resolved and RASH (rash on chest and arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: New AE added, Reporter details added. On 01-Oct-2021: Follow up received contains no new information.
Pinpoint papules developed on both thighs within 48 hours of vaccination.  Unsure about itching clinical appearance suggestive of folliculitis.  Treated with topical bactroban.
Hives, Cluster of 2 patients (sisters - no individual patient identification provided) developed hives the next day after receiving Menactra (lot number U1932AB, route and site administration not reported) on 09 April 2007, received from a health care professional in the USA on 27 April 2007. Case 2:  A female patient (one of 2 sisters) developed hives on the arms and legs, the next day after she received Menactra (lot number U1932AB, route and site of administration not reported) on 09 April 2007. It was unknown if any other vaccines were administered within 4 weeks. The patient was treated by her father, who is a dermatologist, with an unknown medication and the event resolved. The first sister's case is detailed in case 2007-01458.
Shingles or C6 distribution treats with oral Acyclovir with prompt resolution.
blood pressure was 200/92 constant; Immediately following the 1st vaccine of Pfizer, I started receiving heart palpitations and extreme dizziness/lightheadedness.  For 3 weeks following the vaccine, my heartrate was in the constant 140s; Immediately following the 1st vaccine of Pfizer, I started receiving heart palpitations and extreme dizziness/lightheadedness.  For 3 weeks following the vaccine, my heartrate was in the constant 140s; Immediately following the 1st vaccine of Pfizer, I started receiving heart palpitations and extreme dizziness/lightheadedness.  For 3 weeks following the vaccine, my heartrate was in the constant 140s; short of breath; He also had abnormal EKG; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: PFR; EM9810 via an unspecified route, administered in left arm on 09Feb2021 at 11:30 (31-year-old at vaccination) as a dose 1, single for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications within two weeks of vaccination. Vaccination facility type was reported as Hospital. The patient had not received any other vaccine in four weeks prior to vaccination. Prior to vaccination the patient was not diagnosed with Covid. On 09Feb2021 at 11:30, immediately following the 1st vaccine of Pfizer, he started receiving heart palpitations and extreme dizziness/lightheadedness. For 3 weeks following the vaccine, his heartrate was in the constant 140s and his blood pressure was 200/92, constant. Every day he was very lightheaded, dizzy and short of breath. He also had abnormal EKG. These adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 200/92, stress test: unknown result, Echocardiogram: abnormal on an unknow date in 2021. Post vaccination the patient was not tested for Covid. Treatment medication such as Metoprolol was taken as result of events. The outcome of the events was unknown.
Patient came into the pharmacy today at 1pm to show me her arm. Her daughter states that she called the pharmacy on Saturday (7/22/17) to alert the staff  of the reaction. Upon reviewing her arm I saw a dark red blotch at the site of injection. Patient states that it does not hurt, does not feel a bump, nor does it feel hot to the touch. She does complain of itchiness. She says that there were no fevers thus far. The redness has not improved, nor has it gotten any better since Saturday. I told her I would inform her primary care physician and advised her to not put anything on her arm. Patient was thinking about putting alcohol on the arm to help with the itch. I advised her not to. I told her to keep monitoring he site and if there are any changes in redness or if it starts to hurt or if she develops a fever that she should contact myself or her physician immediately.
Severe nausea beginning less than 12 hours after dose followed by severe headache, muscle aches, and fever/chills. Also experienced dizziness and slight disorientation. These symptoms  are starting to diminish around 24 hours after dose except for the nausea. Pain in the arm and injection site still seems above average - worse than a tetanus shot.
This spontaneous case was reported by a dentist and describes the occurrence of ANOSMIA (Loss of smell) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced ANOSMIA (Loss of smell). At the time of the report, ANOSMIA (Loss of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.; Reporter's Comments: Based on the information provided, a temporal association between the reported events and administration of mRNA-1273 vaccine, and excluding any other etiology, a causal association cannot be excluded
After 9 days woke up with red, warm to touch patch of skin- tender to touch - some aches under arm pit.   Low level fatigue.
This patient requested evaluation of past AVA reaction during a mass deployment immunization sceening on 06 Jan 2006.  He reported receiving his first anthrax vaccination on 7 Mar 01 with commonly reported symptoms of site tenderness, redness and a nodule/lump formation that lasted approximately one week.  His second AVA was administered on 3 Mar 01 with similar reactions that lasted approximately 2 weeks.  His third vaccination was administered on 23 Apr 01 with similar reactions however the redness now included the vaccine site, entire tricep area of arm from shoulder to elbow. There was no paresthesia, weakness or problems using his arms. This lasted approximately 2 weeks.  His fourth AVA was administered 01 Feb 2003 with similar reactions.  The site burned, became swollen and red extending from his shoulder past his elbow without axillary lymphadenopathy or lower extremity paresthesia.  He noted sudden onset of throbbing radiating frontal headaches that encompassed his head. He is alway photophobic and he did not notice any exacerbation of symptoms. He denied nausea, vomiting, difficulty breathing, chest pain, neck or back pain, limited use of extremities, or weakness.  These symptoms lasted approximately 3 weeks using Naprosyn for pain that was prescribed by his units corpsman.  A VAERS was filed (2/2003).  He has not received any further AVA vaccinations and was advised not to by this corman.  His medical records contain only the VAERS and no further documentation of the event.
Student was sent down to the office with complaints of numbness in right hand and arm. When student got to me she couldn't feel her right hand, arm and it traveled up to her face, with the right side of her tongue being numb and then her nose being totally numb. Did a complete neurological check and she didn't have any neuro deficits at the time. Had her sit with me, drink water to see if she could feel her tongue. Student sat with me until the feeling came back. Student went back to class and I called home. Student picked up immediately and brought to Pediatrician. Student was told to see a neurologist.
Paresthesia of bilateral feet and lower extremities initially, then neuropathic pain in same stocking distribution, then similar but less intense paresthesia and neuropathic pain of bilateral hands
Rheumatoid arthritis flares and symptoms have gotten much worse, and overall health significantly declined after second vaccine in September. Cluster migraine headache cycle started in October, and RA flares became much worse.  Cluster migraine cycle has lasted three to four months. Questioning whether or not the prescribed Xeljanz stopped working as a result of vaccine. Will not be getting a booster, due to completely not feeling well.
This spontaneous report as received from a nurse refers to 12 patients of unknown age and gender. The nurse reported that 12 doses of oral ROTATEQ were administered to 12 unspecified patients on unspecified dates, that may or may not have been contained in partially or completely unsealed foil pouches. The nurse was not certain how many of the 12 doses of oral ROTATEQ that were administered may have been contained in partially or completely unsealed foil pouches, but she was certain that no adverse experience had been observed or reported. Of the remaining 13 doses of oral ROTATEQ from that carton, 4 doses were contained in a foil pouch that was partially sealed on one end and 3 doses were contained in a foil pouch that was completely open on one end. Additional information has been requested.
lip swelling, pain in ear and throat, felt a slight bump in the side of the neck, pain was on the side of injection lasted for about 24 hours